BCR-ABL Activity Is Critical for the Immunogenicity of Chronic Myelogenous Leukemia Cells
Katharina M. Brauer(University of Tübingen), Peter Brossart(University of Tübingen)
Cited by 50
Related Papers
Analysis of the anti-proliferative and the pro-apoptotic efficacy of Syk inhibition in multiple myeloma
|Experimental Hematology and Oncology|2015|31